(Q44473012)

3 December 2017

title

Strong correlations between circulating chemerin levels and lipoprotein subfractions in nondiabetic obese and nonobese subjects (English)

1 reference

3 December 2017

0 references

1 reference

3

1 reference

3 December 2017

Hajnalka Lőrincz

1

1 reference

3 December 2017

Mónika Katkó

2

1 reference

3 December 2017

Sándor Somodi

4

1 reference

3 December 2017

Krisztina Gaál

5

1 reference

3 December 2017

Péter Fülöp

6

1 reference

3 December 2017

György Paragh

7

1 reference

3 December 2017

Ildikó Seres

8

1 reference

3 December 2017

publication date

5 December 2013

1 reference

3 December 2017

published in

Clinical Endocrinology

1 reference

3 December 2017

volume

81

1 reference

3 December 2017

issue

3

1 reference

3 December 2017

page(s)

370-377

1 reference

Clinical relevance of adipokines

3 December 2017

cites work

1 reference

Chemerin is a novel adipokine associated with obesity and metabolic syndrome

21 January 2018

1 reference

Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades

21 January 2018

1 reference

Chemerin: at the crossroads of inflammation and obesity

21 January 2018

1 reference

Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism

21 January 2018

1 reference

Chemerin levels are positively correlated with abdominal visceral fat accumulation.

21 January 2018

1 reference

Serum chemerin levels are associated with the presence and extent of coronary artery disease

21 January 2018

1 reference

Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome

21 January 2018

1 reference

Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery

21 January 2018

1 reference

Lipoprotein subfractions and cardiovascular disease risk

21 January 2018

1 reference

Oxidized LDL and HDL: antagonists in atherothrombosis

21 January 2018

1 reference

Antiatherogenic small, dense HDL--guardian angel of the arterial wall?

21 January 2018

1 reference

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

Dense low density lipoproteins and coronary artery disease

21 January 2018

1 reference

High-density lipoprotein subclasses and their relationship to cardiovascular disease.

21 January 2018

1 reference

Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes

21 January 2018

1 reference

Elevated plasma levels of chemerin in newly diagnosed type 2 diabetes mellitus with hypertension

21 January 2018

1 reference

Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes.

21 January 2018

1 reference

Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis.

21 January 2018

1 reference

In vitro simultaneous transfer of lipids to HDL in coronary artery disease and in statin treatment

21 January 2018

1 reference

Uremia alters HDL composition and function

21 January 2018

1 reference

Health benefits of high-density lipoproteins in preventing cardiovascular diseases.

21 January 2018

1 reference

Antiinflammatory properties of HDL.

21 January 2018

1 reference

Mouse ChemR23 Is Expressed in Dendritic Cell Subsets and Macrophages, and Mediates an Anti-Inflammatory Activity of Chemerin in a Lung Disease Model

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CEN.12363

1 reference

3 December 2017

1 reference